Steven H. Kleinman

发表

Sensitivity comparison of two Food and Drug Administration–licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield

J. Saldanha, D. Krysztof, S. Stramer, 2011, Transfusion.

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection

S. Glynn, S. Kleinman, M. Busch, 2005, Transfusion.

The Leukocyte Antibody Prevalence Study‐II (LAPS‐II): a retrospective cohort study of transfusion‐related acute lung injury in recipients of high‐plasma‐volume human leukocyte antigen antibody–positive or –negative components

O. Gajic, D. Triulzi, R. Hubmayr, 2011, Transfusion.

Long‐term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma

S. Kleinman, M. Busch, P. Norris, 2009, Transfusion.

West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual‐donation nucleic acid testing

P. Tomasulo, M. Busch, S. Kleinman, 2009, Transfusion.

Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood‐donor screening

S. Kleinman, M. Busch, L. Tobler, 2003, Transfusion.

A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors

S. Glynn, D. Brambilla, R. Dodd, 2017, Transfusion.